Wall Street Zen upgraded shares of Henry Schein (NASDAQ:HSIC – Free Report) from a hold rating to a buy rating in a report issued on Saturday morning. Weiss Ratings reissued a “hold (c+)” rating on shares of Henry Schein in a research note on Monday, May 4th. Get Henry Schein alerts:Get Our Latest Stock Report on Henry ScheinHenry Schein Trading Up 0.9%NASDAQ:HSIC opened at $86.51 on Friday. Henry Schein Company Profile(Get Free Report)Henry Schein, Inc is a leading global distributor of healthcare products and services, primarily serving office-based dental, medical and animal health practitioners. Recommended StoriesReceive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.